KLHDC7B and breast carcinoma: Previous studies on breast cancer provided evidence that KLHDC7B was upregulated in breast tumors, but they also revealed that the expression of KLHDC7B was grade-dependent and only significantly upregulated in grade 3 tumors, indicating that KLHDC7B was associated with more aggressive tumors and worse prognosis (26).